Prothena
PRTA
#6872
Rank
NZ$1.03 B
Marketcap
NZ$19.16
Share price
-0.81%
Change (1 day)
-20.37%
Change (1 year)

Earnings for Prothena (PRTA)

Earnings in 2025 (TTM): -NZ$0.39 Billion

According to Prothena's latest financial reports the company's current earnings are NZ$11.78 Million. In 2024 the company made an earning of -NZ$0.27 Billion, an increase over its 2023 earnings that were of -NZ$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prothena from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.39 Billion43.78%
2024 -NZ$0.27 Billion-19.09%
2023 -NZ$0.34 Billion45.21%
2022 -NZ$0.23 Billion-282.78%
2021 NZ$0.12 B-163.84%
2020 -NZ$0.2 Billion33.94%
2019 -NZ$0.15 Billion-44.78%
2018 -NZ$0.27 Billion-0.97%
2017 -NZ$0.27 Billion-3.33%
2016 -NZ$0.28 Billion99.17%
2015 -NZ$0.14 Billion1102.24%
2014 -NZ$11.51 Million-83.55%
2013 -NZ$69.98 Million-2.37%
2012 -NZ$71.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
NZ$0.70 B-282.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-158.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amarin Corporation
AMRN
-NZ$0.15 Billion-61.71%๐Ÿ‡ฎ๐Ÿ‡ช Ireland